South Korean Pharmaceuticals & Biotech Upcoming Dividends

JW Holdings

Market Cap: ₩289.2b

Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.

JW Lifescience

Market Cap: ₩198.8b

Provides national infusion solutions in South Korea and internationally.

Sam-A Pharm

Market Cap: ₩99.1b

Operates as a pharmaceutical company in South Korea.

JW Pharmaceutical

Market Cap: ₩691.1b

Manufactures and sells medicines and medical supplies in Japan and internationally.

Seoulin BioscienceLtd

Market Cap: ₩57.0b

A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.

Huons Global

Market Cap: ₩815.2b

Manufactures and sells pharmaceutical products for human health in South Korea and internationally.

Boryung

Market Cap: ₩828.8b

Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.